A new device from NeuroInterventions, Inc., is designed to minimize brain damage by dramatically speeding the delivery of post-stroke countermeasures.
“Stroke is the third most frequent cause of death, and the number-one cause of permanent disability,” says NeuroInterventions President and COO Michele Migliuolo [mil-u-OLO]. “When a clot blocks the flow of oxygen-rich blood in the brain, [...]
Children with functional abdominal pain who used audio recordings of guided imagery at home in addition to standard medical treatment were almost three times as likely to improve their pain problem, compared to children who received standard treatment alone.
And those benefits were maintained six months after treatment ended, a new study by University of North [...]
Bio-Matrix Scientific Group, Inc. (OTCBB: BMSN) provided a progress report on the Company’s previously announced new opportunities. The Company has been moving forward in the areas of stem cell research for treatment of Chronic Obstructive Pulmonary Disease (COPD), Tumor Banking and Cancer Treatment.
The Company is in the process of forming a relationship with a medical [...]
Arch Pharmalabs, Ltd., a leading provider of small molecule process R&D and full life-cycle custom synthesis and manufacturing services, announced today it has entered into a strategic partnership with Orochem Technologies, Inc., to manufacture a U.S. innovator’s active pharmaceutical ingredient (API) in late-stage clinical development using Simulated Moving Bed (SMB) technology. Orochem Technologies manufactures SMB [...]
FDA Approves Berinert to Treat Abdominal Attacks, Facial Swelling Associated With Hereditary Angioedema
The U.S. Food and Drug Administration today approved Berinert, the first treatment for acute abdominal attacks and facial swelling associated with a rare and potentially life-threatening genetic disease called hereditary angioedema (HAE).
Berinert is approved for adults and adolescents with HAE, which can occur [...]
Recent Comments